Toby M. Maher
Impact in
- Pulmonary and Respiratory Medicine top 0.02%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Medical Imaging and Pathology Studies
- Pulmonary Hypertension Research and Treatments
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory and Cough-Related Research
- Pathology and Forensic Medicine top 0.1%
- Systemic Sclerosis and Related Diseases
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 319
- Chronic Obstructive Pulmonary Disease (COPD) Research 37
- Medical Imaging and Pathology Studies 35
- Pulmonary Hypertension Research and Treatments 29
- Inhalation and Respiratory Drug Delivery 23
- Respiratory and Cough-Related Research 19
-
- Systemic Sclerosis and Related Diseases 64
- Co-authors
- Athol U. Wells (81 shared papers)Elisabetta Renzoni (56 shared papers)Philip L. Molyneaux (83 shared papers)Michael Kreuter (56 shared papers)David M. Hansell (16 shared papers)Marlies Wijsenbeek (41 shared papers)Paolo Spagnolo (20 shared papers)Andrew G. Nicholson (23 shared papers)
- Journals
- Thorax (37 papers)European Respiratory Journal (29 papers)American Journal of Respiratory and Critical Care Medicine (28 papers)Respirology (17 papers)ERJ Open Research (15 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Toby M. Maher
399 papers receiving 16.3k citations
Toby M. Maher's Hit Papers
Peers
Comparison fields: 5 of 155
- Pulmonary and Respiratory Medicine 11.7k
- Pathology and Forensic Medicine 3.1k
- Physiology 2.7k
- Rheumatology 862
- Epidemiology 1.7k
Countries citing papers authored by Toby M. Maher
This map shows the geographic impact of Toby M. Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toby M. Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toby M. Maher more than expected).
Fields of papers citing papers by Toby M. Maher
This network shows the impact of papers produced by Toby M. Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toby M. Maher. The network helps show where Toby M. Maher may publish in the future.
Co-authors
The 25 scholars most cited alongside Toby M. Maher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 435 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease Hit paper breakdown → | 2019 | 1013 |
| 2 | Interstitial Lung Disease in Systemic Sclerosis Hit paper breakdown → | 2008 | 890 |
| 3 | Idiopathic pulmonary fibrosis: Disease mechanisms and drug development Hit paper breakdown → | 2020 | 426 |
| 4 | Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial Hit paper breakdown → | 2019 | 411 |
| 5 | The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2014 | 403 |
| 6 | Global incidence and prevalence of idiopathic pulmonary fibrosis Hit paper breakdown → | 2021 | 373 |
| 7 | 2020 | 353 | |
| 8 | Interstitial lung diseases Hit paper breakdown → | 2022 | 287 |
| 9 | 2012 | 271 | |
| 10 | 2007 | 265 | |
| 11 | 2009 | 265 | |
| 12 | 2016 | 249 | |
| 13 | 2017 | 239 | |
| 14 | 2015 | 223 | |
| 15 | 2013 | 204 | |
| 16 | 2013 | 203 | |
| 17 | 2019 | 202 | |
| 18 | 2019 | 185 | |
| 19 | 2009 | 182 | |
| 20 | 2012 | 180 |
About Toby M. Maher
Toby M. Maher is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Physiology, Epidemiology and Molecular Biology, having authored 435 papers that have together received 16.6k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (319 papers), Systemic Sclerosis and Related Diseases (64 papers), Sarcoidosis and Beryllium Toxicity Research (40 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (37 papers), Medical Imaging and Pathology Studies (35 papers), Pulmonary Hypertension Research and Treatments (29 papers), Inhalation and Respiratory Drug Delivery (23 papers) and Respiratory and Cough-Related Research (19 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (11.7k citations), Pathology and Forensic Medicine (3.1k citations), Physiology (2.7k citations), Rheumatology (862 citations) and Epidemiology (1.7k citations). Toby M. Maher has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Athol U. Wells, Elisabetta Renzoni, Philip L. Molyneaux, Michael Kreuter, David M. Hansell, Marlies Wijsenbeek, Paolo Spagnolo, Andrew G. Nicholson, Vincent Cottin and Susanne Stowasser. Their work appears in journals such as Thorax, European Respiratory Journal, American Journal of Respiratory and Critical Care Medicine, Respirology and ERJ Open Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.